Day One Biopharmaceuticals, Inc. (DAWN)

8.61 +0.36 (+4.36%) USD  |  NASDAQ  |  Dec 17, 15:17
More

Day One Biopharmaceuticals Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade